century, as science and knowledge play an ever-greater role in peoples' lives?
Venkatraman Ramakrishnan (VR): The general goal of the Royal Society has not changed for 350 years: it is the promotion of knowledge for the benefit of humanity. How you pursue that fundamental goal has obviously changed over the years. Science in the 21 st century is an enormously bigger enterprise than it was in the 1600s, and our society is increasingly technological. So one goal is to ensure that science is adequately supported. In a democratic society, there has to be public support for science, and this leads to making sure that the public is informed about science, which has vastly improved the standard of living we enjoy today over the past 200 to 300 years. The other aspect of science is cultural, which is that it is increasing humanity's store of knowledge. People often underestimate how interested the average non-scientific person is about science. I've talked to people from all walks of life and they're very excited and curious; they often ask me about my work, they ask intelligent questions and they're quite happy to support science. This leads to education: we have to make sure, starting right from school, that our young people are trained properly in science. And, finally, the Royal Society has always promoted international collaborations and exchanges in science. Take, for example, Antoniee van Leeuwenhoek: he was not originally a scientist, but he made the first powerful microscopes and many discoveries. These were first published by the Royal Society and gained him international recognition. ER: Another aspect is the Society's influence on politics and on policy-making, particularly in the UK, similar to the influence of the US National Academy of Science in the USA. National academies in other countries such as Germany, China VR: I honestly don't know what the history of it is. But I think one reason that the Royal Society policy studies are highly respected is because they're impartial and represent the best opinions that science has currently in any particular field. You can see from the Society's stand on various issues like GMO crops or climate change that they don't have any particular political agenda and go where the evidence leads them. And when I say the Royal Society, it's really a committee of experts. It's not that the president is pronouncing on every issue. The studies are done by experts, and I would be just a spokesman.
ER: Given the influence the Society has had not just on Britain, but outside Britain as well, do you think we would need an academy of scientists in Brussels to advise politics on the European level?
VR: Yes, I suppose it might be useful, but you would have to ask what this commission would do that the various national academies, including the Royal Society, don't already do. And the real question is: is there some additional benefit to having an EU voice? I don't have any particular opinion about it.
ER: You mentioned education: in light of the anti-scientific movements against GMOs or vaccination, how can an academic society help to overcome these attitudes?
VR: We live in an increasingly scientific society and decisions are often made on highly technical grounds. And if the average person doesn't understand the basis on which various decisions are being made-I don't mean to understand all the technical details, but at least the fundamental ideas behind decisions-then it's not a good thing for democracy. So I think the public level of interest in science and knowledge of science needs to be raised. But the other thing is that, for various issues, scientists in the field need to become more active. They need to go out and speak to people, engage with the media and so on, to explain why certain decisions are correct and based on the best information we have. Now occasionally our views can change as new data become available, so I wouldn't say that we're always right. And that's another important concept to communicate to people: that we always live with uncertainty. Even in our daily lives, there's constant uncertainty. So that's just part of life, and science has a way of evaluating what the uncertainties are, and we incorporate them in our decisions.
ER: How do you explain, then, that after Andrew Wakefield's paper on a link between vaccination and autism was retracted, and after it was shown that his claims are completely unfounded, that his work still has such an influence on people's opinions about vaccination?
VR: I think partly this is the fault of the media. The media like something that's dramatic and makes the headlines. If you read the news, it always appears to be a series of disasters, but positive events are not so well reported. In these cases, the initial story makes big headlines. There was a case about electric transmission wires causing cancer, and that too turned out not to hold up on close examination. And when the careful study is done, and the original finding is disproved or shown to have no basis, that isn't reported as widely. In the public's mind, what they remember is the original scare story. So scientists need to engage with the media and make sure that the correction makes as big an impact. It actually has to make an even bigger impact, because it now has to turn around people's feelings.
ER: In that regard, what do you think of the academic discussions about moratoria? Last year, we saw a discussion about the H5N1 gain-of-function experiments by Fouchier and Kawaoka and a call for a moratorium on gain-of-function experiments in virology. And now we have a discussion about a moratorium on CRISPR/Cas technology.
VR: I think these discussions are very good and it reminds me of the Asilomar conference on recombinant DNA in the 1970s. It wasn't that scientists thought that there was a huge danger, but they saw possible dangers, and they thought it was best to discuss this openly and to err on the side of caution. And that worked very well. In fact, recombinant DNA technology is now a multi-billion-dollar industry and a lot of medicine depends on it. I don't think it actually slowed things down much, but it prevented people from doing foolish things. So it is not at all a bad idea to have a transparent discussion on the potential benefits and risks of any new technology and then decide on a set of procedures. And by doing so, you also create public trust; you create the feeling that scientists are responsible people who care about society.
ER: Speaking of trust, we are seeing an apparent increase in retractions and cases of misconduct and fraud in research recently. Do you see that this as undermining public trust in science?
VR: You could look at it two ways. You could say: well, it's still a tiny fraction of the total number of papers published. If that were the level of retractions in any other field, it would be considered exceptional. And the only reason that it's a big deal in science is that science is expected to be rational and accurate. But human nature being what it is, people will take shortcuts,
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The next president of the Royal Society Holger Breithaupt they will over interpret or misinterpret data, and occasionally they will be tempted to falsify data. I would say that all these retractions actually show that the scientific process is working, because the errors are being discovered and they're openly being retracted. Scientists are not always completely rational; they have their flaws. But science as a process is a very rational enterprise. So you have to distinguish between science and individual scientists. ER: Related to this is the discussion about structural or systemic reasons why people cut corners or commit fraud. One is increasing pressure, particularly on younger scientists, to succeed, to get published in order to get a grant in order to get tenure. Do you see that there's a risk that research assessments put too much pressure on scientists?
VR: I think that's true. First of all, I don't know if the level of fraud has gone up. I'm not saying it hasn't, but I bet you there was fraud 200 years ago.
ER: There are social scientists such as Brian Martinson who say that outright fraud is actually very rare, but we see a lot of what he calls questionable behavior, that we might prevent if we change the structural set up. 
VR:
If you read science history, there's been questionable behavior all along. So again, this goes back to the difference between scientists and the scientific process. But I agree that it's important to encourage ways of acting that reduce this sort of behavior. One problem I think is when mentors, especially those who run large labs, and who are not quite in touch with the details of what's going on, want results. And then they put pressure on post-docs.
The other problem is this expectation in science that everybody has to end up in a tenure track position. In fact there are lots of interesting science jobs, even if they're not tenure track laboratory-based science. But because that's artificially set up as a gold standard for success, people feel tremendous pressure to get high-profile papers. That leads to another problem. Why is it that they need papers only in certain journals? This has to do with the laziness of awards committees, fellowship committees, hiring committees, promotion committees. Instead of asking, what did this person actually achieve, is this person a good scientist, they too often ask if this person has a paper in Science, Nature or Cell and then put them in pile A. I've talked to people on various committees, and often it's: "oh, that person didn't have any first-author high-profile papers". This automatically discourages collaboration and encourages splashy papers. I think we're all at fault there, and the system needs to change.
ER: What would you do to change that? VR: I can be an advocate, but let's be honest, even the entire Royal Society doesn't have any specific power to change this. What we have is an influential opinion. Perhaps this is something that could be studied, and we could come up with a practical set of recommendations on what sort of behavior do we want to promote among more senior scientists. But actually, younger group leaders may be under even more pressure, because they have to get tenure, so they transmit that pressure down to their post-docs and students. This needs to be aired more, and it needs to be thought about more, to see what sort of practical things we can do. Everyone understands the problem, but it's a difficult thing to change.
ER: Do you see institutions that are good models in that regard?
VR: I like to think that my own institute is an excellent model. The last three people we've hired in my division in permanent or tenure track positions, are all people who didn't have any Science, Nature or Cell papers. I mean, they got them after they came to the LMB, as a result of the work they did here, but when we hired them they didn't have any such papers. But we knew that they were very good in their field, and we knew that we wanted to support the kind of work that they were doing. If everybody were to do that sort of thing, then I think the system could change.
ER: Another aspect is the role of women in science. We have more or less equal representation at the undergraduate and graduate level, but then a dramatic drop off of female scientists at the post-doc to group leader level. What do you think are the reasons, and how should we address this? VR: I think the reasons are highly complex. It has to do with a very rigid career structure in science, which doesn't allow for breaks, which doesn't allow for balance between family and work. These things obviously need to change. Of course, to some extent attitudes also need to change. And by attitude, I don't mean a blatantly sexist attitude, but more subtle prejudices, including aspects of what it takes to be competitive in science. The Royal Society now has a diversity committee, which is headed by Uta Frith, a distinguished scientist, to find out what the structural reasons are for this problem, which seems to persist despite all the equality laws. The hope is that the committee will inform the science community about their findings and recommendations for what can be done. That I hope could be the basis for starting a long-term change to improve things.
ER VR: I think they're both useful and complementary in many ways. Some things like the ERC are simply alternative sources of funding, which are intended to support the best science in Europe regardless of nationality. They can be particularly helpful if your own nation has a scarcity of funds. For example, let's say you live in one of the former Eastern Bloc or Southern European countries where national funding is limited, and you happen to be an exceptionally good scientist, then the ERC is an excellent option to support you. It's true for British scientists as well. If they have a shortage of funds they can apply to the ERC. Then there are other kinds of grants, which promote Europeanwide collaboration. This could involve complementary expertise or complementary interests, and that I think is very good for VR: I have to say I'm not much in favor of these top-down initiatives. I think innovation is a highly complex issue and it depends on encouraging a culture where business interests and scientists can come together and talk, where scientists keep in mind potential applications and where they have easily available mechanisms to start a business. I'm not sure that kind of thing can be achieved by top-down initiatives. I think if they're top-down initiatives, they should be funded with extra money. But if they're going to take money away from basic science, that would be a mistake. If you look at all of the big revolutionary industries from monoclonal antibodies to recombinant medicines, they all came as a result of basic science. These are the really big transforming technologies. And if you take money away from basic science, you're ensuring that 20 or 30 years down the line, you won't have those transformative technologies. If, on the other hand, they want to make it easier for scientists to implement practical applications of their research, to facilitate technology transfer, they can provide money specifically to help with that.
ER: Another trend in European funding is that the majority of the beneficiaries of both ERC grants and Horizon 2020 money work in northern and western European countries. These countries have a rich and solid tradition of research and they are successfulsome say at the expense of the southern and eastern countries, both in terms of funding and brainpower. Do you see a danger that the traditional scientific powers in Europe are. . . VR: . . .sucking up all of the resources? Yes, I think this is a problem. But on the other hand, if you then go to a quota system, you're not going to necessarily support the best science. The advantage of the current system is that, even if the money goes disproportionately to a few scientifically advanced countries in Europe-and I know Britain is one of the beneficiaries-that in the EU context it will encourage good scientists from other countries to go where the money is. You are supporting young scientists throughout the EU. And many of these scientists then go back and set up labs in their home countries. Some of them don't, and that's the price we pay for an overall improvement. But I think in the long run it will actually benefit Europe as a whole, although I admit that there are disparities. Actually, it's not such a long run, because if you look at the level of science in southern European countries before there was the EU, and compare it to their science today, I think no one would suggest that research in southern Europe has not improved dramatically. When I say "long run", I mean a day when they'll be sort of equal: that could be a long run. But they're already improving.
ER 
When you say "India and China", you're implying that they're somehow comparable, but they aren't. China is investing far more in science and in research infrastructure than India, and today there's really no comparison between the two, although of course there are individual labs in India that are very good. And unless European countries invest more in science, they're going to fall behind. I'm particularly worried about Britain, where the science budget has been flat for the last five years and as a result has actually lost in real terms due to inflation. We in the West have had an historic advantage, but we may lose that advantage to Asian countries-Singapore for instance-that invest heavily in science and have attracted a lot of European and American scientists. Well, you could take a neutral attitude and say this is just part of historyvarious nations rise and fall-but I would hate to see Europe, where the modern scientific method was born and where so many revolutionary discoveries were made, go into a decline. I think we need to invest more and support science in a more stable manner.
ER: Dr. Ramakrishnan, many thanks for the interview. 
EMBO reports
The next president of the Royal Society Holger Breithaupt
